Empresa PhaseBio Pharmaceuticals, Inc.
Acciones
PHAS.Q
US7172241090
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,000001 USD | 0,00 % | 0,00 % | 0,00 % |
Resumen de negocios
Número de empleados: 60
Ventas por actividad
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapies
100,0
%
| 0 | 100,0 % | 11 | 100,0 % | +3.284,69 % |
Ventas por región
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 11 | 100,0 % | +3.284,69 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Mow
CEO | Chief Executive Officer | 59 | 04/12/12 |
Lawrence Perkins
DFI | Director of Finance/CFO | 47 | 01/10/22 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 18/04/16 |
Susan Arnold
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/10/10 |
General Counsel | 52 | 01/10/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Edmund Harrigan
BRD | Director/Board Member | 71 | 13/12/18 |
Jonathan Mow
CEO | Chief Executive Officer | 59 | 04/12/12 |
Director/Board Member | 57 | 14/09/21 | |
Nancy Hutson
BRD | Director/Board Member | 74 | 05/03/18 |
Clay Thorp
FOU | Founder | 55 | 10/01/02 |
Director/Board Member | 57 | 27/02/19 | |
Alex Sapir
BRD | Director/Board Member | 57 | 12/02/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 49 888 083 | 49 767 625 ( 99,76 %) | 29 967 ( 0,0601 %) | 99,76 % |
Información de la empresa
PhaseBio Pharmaceuticals, Inc.
3500 South Dupont Highway Kent County
19901, Dover
+610 981 6500
http://www.phasebio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
0,00 % | 49 | |
-2,31 % | 103 mil M | |
+0,56 % | 95,71 mil M | |
+1,69 % | 22,02 mil M | |
-17,37 % | 20,9 mil M | |
-9,30 % | 17,85 mil M | |
-41,01 % | 16,21 mil M | |
-14,85 % | 15,52 mil M | |
+3,21 % | 13,86 mil M | |
+33,54 % | 12,04 mil M |
- Bolsa de valores
- Acciones
- Acción PHAS.Q
- Empresa PhaseBio Pharmaceuticals, Inc.